Status:

COMPLETED

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

Lead Sponsor:

Sinovac Biotech Co., Ltd

Conditions:

Hand, Foot and Mouth Disease

Eligibility:

All Genders

6-35 years

Brief Summary

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Detailed Description

The phase III, efficacy trial of inactivated vaccine (vero cell) against EV71 has completed on March 2013 in China,and a follow up study for phase III clinical trial has completed on March 2014. On t...

Eligibility Criteria

Inclusion

  • In the prior phase III clinical trial, 10077 subjects in three counties (Ganyu, Sheyang and Taixing ) were enrolled ( Experimental group: 5044; Control group: 5043 ), with 1293 of them in immunogenicity subgroup (Experimental group: 648; Control group: 645). In Sheyang county, 3351 subjects were enrolled (Experimental group: 1676 ; Control group :1675) , with 435 of them in immunogenicity subgroup (Experimental group: 418 ; Control group :418).
  • The subjects in Sheyang immunogenicity subgroup with the following conditions were included in this study:
  • Guardian(s) of the volunteer should be capable of understanding the written consent form, and such form should be signed before the infant being included into this study
  • Received at least one injection of EV71 vaccine or the placebo in the phase III clinical trial
  • Finished the blood sampling 64 months after the vaccination

Exclusion

  • Received extra EV71 vaccination after the phase III clinical trial
  • Refused to join the study

Key Trial Info

Start Date :

May 20 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 21 2017

Estimated Enrollment :

343 Patients enrolled

Trial Details

Trial ID

NCT03281174

Start Date

May 20 2017

End Date

May 21 2017

Last Update

September 13 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sheyang Center for Disease Control and Prevention

Yancheng, Jiangsu, China, 210009